STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs
Background
Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier and furthermore, there is no consensus on which medications are considered as FRIDs despite several systematic reviews. To support clinicians in the management of FRIDs and to facilitate the deprescribing process, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk) and a deprescribing tool were developed by a European expert group.
Methods
STOPPFall was created by two facilitators based on evidence from recent meta-analyses and national fall prevention guidelines in Europe. Twenty-four panellists chose their level of agreement on a Likert scale with the items in the STOPPFall in three Delphi panel rounds. A threshold of 70% was selected for consensus a priori. The panellists were asked whether some agents are more fall-risk-increasing than others within the same pharmacological class. In an additional questionnaire, panellists were asked in which cases deprescribing of FRIDs should be considered and how it should be performed.
Results
The panellists agreed on 14 medication classes to be included in the STOPPFall. They were mostly psychotropic medications. The panellists indicated 18 differences between pharmacological subclasses with regard to fall-risk-increasing properties. Practical deprescribing guidance was developed for STOPPFall medication classes.
Conclusion
STOPPFall was created using an expert Delphi consensus process and combined with a practical deprescribing tool designed to optimise medication review. The effectiveness of these tools in falls prevention should be further evaluated in intervention studies.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
20
|
|
|
European Geriatric Medicine
19 publications, 10.44%
|
|
|
BMC Geriatrics
13 publications, 7.14%
|
|
|
Age and Ageing
12 publications, 6.59%
|
|
|
Drugs and Aging
8 publications, 4.4%
|
|
|
European Journal of Clinical Pharmacology
6 publications, 3.3%
|
|
|
Journal of the American Medical Directors Association
5 publications, 2.75%
|
|
|
Journal of the American Geriatrics Society
5 publications, 2.75%
|
|
|
Scientific Reports
5 publications, 2.75%
|
|
|
Geriatrics and Gerontology International
3 publications, 1.65%
|
|
|
JAMA network open
3 publications, 1.65%
|
|
|
Nursing older people
3 publications, 1.65%
|
|
|
Healthcare
3 publications, 1.65%
|
|
|
PLoS ONE
3 publications, 1.65%
|
|
|
Research in Social and Administrative Pharmacy
3 publications, 1.65%
|
|
|
Frontiers in Public Health
3 publications, 1.65%
|
|
|
International Journal of Clinical Pharmacy
3 publications, 1.65%
|
|
|
Trials
2 publications, 1.1%
|
|
|
Expert Review of Clinical Pharmacology
2 publications, 1.1%
|
|
|
Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions
2 publications, 1.1%
|
|
|
International Journal of Pharmacy Practice
2 publications, 1.1%
|
|
|
Practical Issues in Geriatrics
2 publications, 1.1%
|
|
|
JAMA - Journal of the American Medical Association
2 publications, 1.1%
|
|
|
Frontiers in Pharmacology
2 publications, 1.1%
|
|
|
Revista Espanola de Cirugia Ortopedica y Traumatologia
2 publications, 1.1%
|
|
|
Drug Safety
2 publications, 1.1%
|
|
|
International Journal of Environmental Research and Public Health
1 publication, 0.55%
|
|
|
JMIR Aging
1 publication, 0.55%
|
|
|
BMJ Open
1 publication, 0.55%
|
|
|
American Journal of Lifestyle Medicine
1 publication, 0.55%
|
|
|
2
4
6
8
10
12
14
16
18
20
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Springer Nature
70 publications, 38.46%
|
|
|
Elsevier
21 publications, 11.54%
|
|
|
Wiley
18 publications, 9.89%
|
|
|
Oxford University Press
14 publications, 7.69%
|
|
|
MDPI
9 publications, 4.95%
|
|
|
Frontiers Media S.A.
6 publications, 3.3%
|
|
|
Taylor & Francis
6 publications, 3.3%
|
|
|
American Medical Association (AMA)
6 publications, 3.3%
|
|
|
SAGE
3 publications, 1.65%
|
|
|
RCNi
3 publications, 1.65%
|
|
|
Cold Spring Harbor Laboratory
3 publications, 1.65%
|
|
|
Public Library of Science (PLoS)
3 publications, 1.65%
|
|
|
BMJ
2 publications, 1.1%
|
|
|
Georg Thieme Verlag KG
2 publications, 1.1%
|
|
|
IGI Global
2 publications, 1.1%
|
|
|
JMIR Publications
1 publication, 0.55%
|
|
|
Pensoft Publishers
1 publication, 0.55%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.55%
|
|
|
Joint Commission Resources Inc.
1 publication, 0.55%
|
|
|
Deutscher Arzte-Verlag GmbH
1 publication, 0.55%
|
|
|
SLACK
1 publication, 0.55%
|
|
|
Endocrinology Research Centre
1 publication, 0.55%
|
|
|
SMW Supporting Association
1 publication, 0.55%
|
|
|
Walter de Gruyter
1 publication, 0.55%
|
|
|
Scientific Scholar
1 publication, 0.55%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.55%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.